AU2020104369A4 - Preparation Method of Active Peptide for Enhancing Selenium Absorption and Application Thereof - Google Patents
Preparation Method of Active Peptide for Enhancing Selenium Absorption and Application Thereof Download PDFInfo
- Publication number
- AU2020104369A4 AU2020104369A4 AU2020104369A AU2020104369A AU2020104369A4 AU 2020104369 A4 AU2020104369 A4 AU 2020104369A4 AU 2020104369 A AU2020104369 A AU 2020104369A AU 2020104369 A AU2020104369 A AU 2020104369A AU 2020104369 A4 AU2020104369 A4 AU 2020104369A4
- Authority
- AU
- Australia
- Prior art keywords
- selenium
- active peptide
- powder
- enhancing
- absorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000011669 selenium Substances 0.000 title claims abstract description 184
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 184
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 182
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 71
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 69
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 75
- 241000251468 Actinopterygii Species 0.000 claims abstract description 55
- 238000000855 fermentation Methods 0.000 claims abstract description 47
- 230000004151 fermentation Effects 0.000 claims abstract description 36
- 239000006228 supernatant Substances 0.000 claims abstract description 22
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 20
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 20
- 235000021119 whey protein Nutrition 0.000 claims abstract description 19
- 210000003097 mucus Anatomy 0.000 claims abstract description 17
- 240000000249 Morus alba Species 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 13
- 244000000626 Daucus carota Species 0.000 claims abstract description 12
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 12
- 240000003183 Manihot esculenta Species 0.000 claims abstract description 12
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims abstract description 12
- 102000008114 Selenoproteins Human genes 0.000 claims abstract description 12
- 108010074686 Selenoproteins Proteins 0.000 claims abstract description 12
- 229920002472 Starch Polymers 0.000 claims abstract description 12
- 239000008107 starch Substances 0.000 claims abstract description 12
- 235000019698 starch Nutrition 0.000 claims abstract description 12
- 230000003068 static effect Effects 0.000 claims abstract description 12
- 238000009210 therapy by ultrasound Methods 0.000 claims abstract description 11
- 241001474374 Blennius Species 0.000 claims abstract description 9
- 235000019483 Peanut oil Nutrition 0.000 claims abstract description 9
- 150000004676 glycans Chemical class 0.000 claims abstract description 9
- 239000000312 peanut oil Substances 0.000 claims abstract description 9
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 9
- 239000005017 polysaccharide Substances 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims description 10
- 102000057297 Pepsin A Human genes 0.000 claims description 6
- 108090000284 Pepsin A Proteins 0.000 claims description 6
- 229940111202 pepsin Drugs 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 4
- 235000013305 food Nutrition 0.000 abstract description 19
- 150000001875 compounds Chemical class 0.000 abstract description 16
- 210000000813 small intestine Anatomy 0.000 abstract description 8
- 235000015097 nutrients Nutrition 0.000 abstract description 6
- 210000001198 duodenum Anatomy 0.000 abstract description 5
- 239000000796 flavoring agent Substances 0.000 abstract description 5
- 235000019634 flavors Nutrition 0.000 abstract description 5
- 210000000936 intestine Anatomy 0.000 abstract description 5
- 235000012041 food component Nutrition 0.000 abstract description 4
- 239000005417 food ingredient Substances 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 229940091258 selenium supplement Drugs 0.000 description 171
- 235000011649 selenium Nutrition 0.000 description 165
- 239000000243 solution Substances 0.000 description 53
- 210000004027 cell Anatomy 0.000 description 26
- 230000029087 digestion Effects 0.000 description 21
- 230000000694 effects Effects 0.000 description 19
- 239000000203 mixture Substances 0.000 description 16
- 230000002496 gastric effect Effects 0.000 description 15
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical group [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 11
- 230000000968 intestinal effect Effects 0.000 description 11
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000233866 Fungi Species 0.000 description 8
- 102000010445 Lactoferrin Human genes 0.000 description 8
- 108010063045 Lactoferrin Proteins 0.000 description 8
- 229920002774 Maltodextrin Polymers 0.000 description 8
- 239000005913 Maltodextrin Substances 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 8
- 235000021242 lactoferrin Nutrition 0.000 description 8
- 229940078795 lactoferrin Drugs 0.000 description 8
- 229940035034 maltodextrin Drugs 0.000 description 8
- 229960001471 sodium selenite Drugs 0.000 description 8
- 235000015921 sodium selenite Nutrition 0.000 description 8
- 239000011781 sodium selenite Substances 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 229940090949 docosahexaenoic acid Drugs 0.000 description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 240000007049 Juglans regia Species 0.000 description 4
- 235000009496 Juglans regia Nutrition 0.000 description 4
- 235000004347 Perilla Nutrition 0.000 description 4
- 244000124853 Perilla frutescens Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 229940082569 selenite Drugs 0.000 description 4
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 235000020234 walnut Nutrition 0.000 description 4
- 239000012981 Hank's balanced salt solution Substances 0.000 description 3
- 239000003833 bile salt Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000014106 fortified food Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000010907 mechanical stirring Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000004252 protein component Nutrition 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000001676 hydride generation atomic fluorescence spectroscopy Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- VRDKYJSLDJDLML-UHFFFAOYSA-N methylselenol Chemical compound [Se]C VRDKYJSLDJDLML-UHFFFAOYSA-N 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003342 selenium Chemical class 0.000 description 1
- -1 selenium ions Chemical class 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/04—Whey; Whey preparations containing non-milk components as source of fats or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A b s t r a c t
The present disclosure belongs to the technical field of food
processing, and specifically relates to a preparation method of an active
peptide for enhancing selenium absorption and application thereof.
According to the present disclosure, a supernatant prepared from fish skin,
whey protein powder, tapioca starch, carrot powder and
selenium-enriched yeast powder are subjected to anaerobic fermentation
to obtain a fermentation solution, and the fermentation solution is added
with selenoprotein and subjected to ultrasonic treatment, then mixed with
a solution consisting of fish skin mucus, mulberry leaf juice, peanut oil
and seaweed polysaccharide, and finally subjected to high static pressure
treatment to obtain the active peptide for enhancing selenium absorption;
the active peptide for enhancing selenium absorption prepared by the
present disclosure mainly includes 6-peptide compounds and 8-peptide
compounds, which are easily absorbed by the small intestine and the
duodenum; at the same time, the structure is stable, the tolerance in the
stomach and intestines is high, and absorption of selenium by the human
body can be effectively enhanced; in addition, the active peptide for
enhancing selenium absorption in the present disclosure can be mutually
matched with other nutrients or food ingredients to prepare
selenium-enriched health-care foods, which have not only high selenium
absorption efficiency but also unique flavors and are easily accepted by
people.
1
Description
A b s tr ac t
The present disclosure belongs to the technical field of food
processing, and specifically relates to a preparation method of an active
peptide for enhancing selenium absorption and application thereof.
According to the present disclosure, a supernatant prepared from fish skin,
whey protein powder, tapioca starch, carrot powder and
selenium-enriched yeast powder are subjected to anaerobic fermentation
to obtain a fermentation solution, and the fermentation solution is added
with selenoprotein and subjected to ultrasonic treatment, then mixed with
a solution consisting of fish skin mucus, mulberry leaf juice, peanut oil
and seaweed polysaccharide, and finally subjected to high static pressure
treatment to obtain the active peptide for enhancing selenium absorption;
the active peptide for enhancing selenium absorption prepared by the
present disclosure mainly includes 6-peptide compounds and 8-peptide
compounds, which are easily absorbed by the small intestine and the
duodenum; at the same time, the structure is stable, the tolerance in the
stomach and intestines is high, and absorption of selenium by the human
body can be effectively enhanced; in addition, the active peptide for
enhancing selenium absorption in the present disclosure can be mutually
matched with other nutrients or food ingredients to prepare
selenium-enriched health-care foods, which have not only high selenium
absorption efficiency but also unique flavors and are easily accepted by
people.
D e s c r i p t io n
Preparation Method of Active Peptide for Enhancing Selenium
Absorption and Application Thereof
Technical Field
The present disclosure belongs to the technical field of food
processing, and specifically relates to a preparation method of an active
peptide for enhancing selenium absorption and application thereof.
Related Art
Selenium is a trace element necessary for the human body and
affects the health and development of the human body. It is recommended
by "Dietary Reference Intakes of Chinese Residents" that 50 micrograms
of selenium is needed every day. Selenium participates in synthesis of
various selenium-containing enzymes and selenoproteins in the human
body, can improve human immunity and promote proliferation of
lymphocytes and synthesis of antibodies and immunoglobulins, and has
obvious inhibition and protection effects on various cancers such as colon
cancer, skin cancer, liver cancer and breast cancer. Methyl selenol, as an
intermediate metabolite of selenium in the human body, has high
anti-cancer activity. Selenium, vitamin E, allicin, linoleic acid,
germanium, zinc and other nutrients have a synergistic antioxidant effect,
so that the antioxidant activity is improved. At the same time, selenium
D e s c r i p t io n
has the effect of reducing and alleviating toxicity of heavy metals. It is
proved by some studies that selenium can effectively inhibit tumor
growth, and an appropriate amount of selenium has a good auxiliary
improvement effect on patients after surgery, radiotherapy and
chemotherapy treatment. In addition, selenium is also the most important
anti-aging element discovered so far. Research by experts from the
Chinese Academy of Sciences on Bama, the home of longevity, show that
the content of selenium in soil and grain of Bama is about 10 times higher
than the national average level, and the content of selenium in the blood
of centenarians is 3 to 6 times higher than that of normal people.
China has a vast territory, and the content of selenium in different
soils varies greatly. In some selenium-deficient areas, the content of
selenium in crops is also low, and the content of selenium in food is not
enough to meet the needs of the human body. Therefore, various
selenium-enriched foods appear on the market. The selenium-enriched
foods, namely foods rich in trace element selenium, generally include
natural selenium-enriched foods (also called plant active selenium foods)
and exogenous selenium-enriched foods (also called artificial organic
selenium foods).
At present, although there are various kinds of foods with a selenium
supplement effect on the market, such as selenium-enriched peanuts and
selenium-enriched rice, most of the selenium supplement foods are
D e s c r i p t io n
expensive but have unclear selenium content. At the same time, the
selenium intake effect of the selenium supplement foods is not
satisfactory due to the influence of digestion and absorption by the human
body. Therefore, it is of great value to develop selenium-enriched
health-care foods capable of improving the selenium absorption
efficiency.
Summary
In order to overcome the shortcomings in the prior art, the present
disclosure provides a preparation method of an active peptide for
enhancing selenium absorption. The binding stability of protein peptide
and selenium can be improved by using biological fermentation and
physical enhancement methods, so that not only can the flavor of a
selenium-enriched peptide be improved, but also the effect of absorbing
selenium by the human body can be improved to achieve the purpose of
selenium supplementation.
In order to achieve the objective, the present disclosure adopted the
following technical scheme:
The present disclosure provides a preparation method of an active
peptide for enhancing selenium absorption, and the method includes the
following steps:
S. preparing fish skin into fish paste, addingpepsin for enzymolysi
D e s c r i p t io n
treatment and collecting the supernatant;
S2. adding whey protein powder, tapioca starch, carrot powder and
selenium-enriched yeast powder into the supernatant obtained in step S1
and then performing anaerobic fermentation;
S3. adding selenoprotein into a fermentation solution obtained in
step S2 and then performing ultrasonic treatment;
S4. uniformly mixing fish skin mucus with mulberry leaf juice,
standing for a period of time, adding peanut oil and seaweed
polysaccharide and then performing homogeneous stirring;
S5. adding a solution obtained in step S4 into a fermentation solution
obtained in step S3, performing vacuumizing and high static pressure
treatment and finally performing depressurization to obtain the active
peptide for enhancing selenium absorption.
Preferably, the fish skin and the fish skin mucus are both from
snakeheaded fish.
Selenium binds to protein to form selenoprotein, which can improve
the structural stability in complex processing environments and digestion
environments. This form of active selenium helps the human body absorb
selenium and improve the bioavailability. According to the present
disclosure, a green and safe selenium-enriched peptide with high
bioavailability is prepared by using the yeast directed fermentation
technology, the stable selenopeptide compound technology and the
D e s c r i p t io n
characteristic of high absorption of peptides. Stable crosslinking of fish
protein and organic selenium is formed under high pressure, a stable
structure is formed by using high static pressure transformation
technology, 6-peptide compounds and 8-peptide compounds which are
easily absorbed by the small intestine and the duodenum are obtained,
and the absorption of organic selenium by intestinal mucosal cells is
enhanced; at the same time, a micro-nano embedding substance can be
formed after a mixture of the body surface mucus of the snakeheaded fish
and the mulberry leaf juice is emulsified, so that the structure of a
selenopeptide compound is not likely to be affected by gastrointestinal
digestion, and the selenopeptide compound can smoothly reach the
absorption site of the small intestine.
Preferably, in order to achieve a better enzymolysis effect, in step Sl,
the added amount of pepsin is 20-40% of the weight of the fish paste.
Preferably, in order to improve the directional fermentation effect, in
step S2, the whey protein powder, the tapioca starch and the carrot
powder are firstly added into the supernatant and heated to 30°C, then the
selenium-enriched yeast powder is added, and finally the temperature is
raised to 37°C for anaerobic fermentation.
Preferably, in order to achieve a better fermentation effect, in step S2,
based on the mass of the supernatant, the added amount of the whey
protein powder is 0.5-1.5%, the added amount of the tapioca starch is
D e s c r i p t io n
2.5-2.8%, the added amount of the carrot powder is 0.3-0.5%, and the
added amount of the selenium-enriched yeast powder is 0.2-0.3%.
Preferably, in order to achieve a better emulsification effect, in step
S4, the volume ratio of the fish skin mucus to the mulberry leaf juice is
1:1.
Preferably, in step S5, the high static pressure treatment is performed
at 300-350 MPa for 10 minutes. The high static pressure treatment is
more conducive to the formation of a stable structure between fish protein
and organic selenium.
Preferably, pH is one of the important conditions affecting the
enzymolysis effect, and in step S1, the pH during the enzymolysis
treatment is 3.8-4.2. Further, the pH during the enzymolysis treatment is
4.0.
Preferably, in order to ensure a sufficient degree of enzymolysis, the
enzymolysis treatment is stirring enzymolysis, and that is to say, stirring
is performed at a rotation speed of 200-300 r/min for 2 hours for
enzymolysis.
Preferably, the temperature is raised to 80°C and maintained for 10
minutes after the enzymolysis treatment to achieve the effects of
sterilization and enzyme inactivation.
Preferably, anaerobic fermentation is terminated when the pH is 4.8.
D e s c r i p t i o n
Preferably, in step S3, the added amount of selenoprotein is
0.001%-0.003% of the total mass of the fermentation solution.
Preferably, in order to ensure that selenoprotein is fully dispersed in
the fermentation solution, in step S3, the powder of ultrasonic treatment
is 300-400 W, and the time is 15-20 minutes.
Preferably, in step S3, the acidity (pH 4.8-5.0) and temperature
(35°C-40°C) of a solution are controlled to be unchanged during
ultrasonic treatment.
Preferably, in step S4, the added amount of the peanut oil is 10-15%
of the total volume of the fish skin mucus and the mulberry leaf juice, and
the added amount of the seaweed polysaccharide is 0.5-0.8 wt% of the
total mass of the fish skin mucus and the mulberry leaf juice.
Preferably, in order to ensure a sufficient degree of stirring, in step
S4, homogeneous stirring is performed at 42°C-46°C for 30-40 minutes.
Preferably, in order to ensure that a selenopeptide compound is fully
emulsified to form a micro-nano emulsion, in step S5, the volume ratio of
a solution obtained in step S4 to a fermentation solution obtained in step
S3 is 1:(4-6). Further, the volume ratio of the solution obtained in step S4
to the fermentation solution obtained in step S3 is 1:5.
Preferably, in step S5, the depressurization is to reduce the pressure
to 80-120 MPa and maintained for 10 minutes.
D e s c r i p t io n
The present disclosure also provides the active peptide for enhancing
selenium absorption prepared by adopting the preparation method.
The present disclosure also provides application of the active peptide
for enhancing selenium absorption in preparation of selenium-enriched
health-care foods.
The active peptide for enhancing selenium absorption is mutually
matched with other nutrients or food ingredients to prepare various forms
of selenium-enriched health-care foods. Not only can healthy nutrients of
the active peptide be improved, various forms of selenium supplement
foods with good selenium absorption effect are formed, but also different
forms of foods are easily accepted by different groups of people due to
different flavors.
The present disclosure also provides a preparation method of a
selenium-enriched emulsion beverage for enhancing selenium absorption,
and the method specifically includes: adding 1.8-2 wt% of whey protein,
0.002-0.003 wt% of lactoferrin, 0.1-0.15 wt% of edible fungus superfine
powder, 1.3-2.0 wt% of maltodextrin, 1.3-2.0 wt% of a perilla extract and
1.3-2.0 wt% of glucose into the active peptide for enhancing selenium
absorption, uniformly stirring and mixing the mixture, and performing
high-temperature sterilization to obtain the selenium-enriched emulsion
beverage for enhancing selenium absorption.
The present disclosure also provides a preparation method of
D e s c r i p t io n
selenium-enriched health-care powder for enhancing selenium absorption,
and the method specifically includes: drying the active peptide for
enhancing selenium absorption into powder, then adding 5-6 wt% of
whey protein powder, 0.6-1.2 wt% of walnut powder, 0.001-0.0015 wt%
of lactoferrin, 0.8-1.0 wt% of edible fungus superfine powder, 8-10 wt%
of maltodextrin and 0.005-0.01 wt% of solid DHA (docosahexaenoic acid)
powder, and performing uniform mixing and packaging to obtain the
selenium-enriched health-care powder for enhancing selenium
absorption.
Compared with the prior art, the beneficial effects of the present
disclosure are:
The present disclosure provides a preparation method of an active
peptide for enhancing selenium absorption. A supernatant prepared from
fish skin, whey protein powder, tapioca starch, carrot powder and
selenium-enriched yeast powder are subjected to anaerobic fermentation
to obtain a fermentation solution, and the fermentation solution is added
with selenoprotein and subjected to ultrasonic treatment, then mixed with
a solution consisting of fish skin mucus, mulberry leaf juice, peanut oil
and seaweed polysaccharide, and finally subjected to high static pressure
treatment to obtain the active peptide for enhancing selenium absorption.
The active peptide for enhancing selenium absorption prepared by the
present disclosure mainly includes 6-peptide compounds and 8-peptide
D e s c r i p t io n
compounds, which are easily absorbed by the small intestine and the
duodenum; at the same time, the structure is stable, the active peptide is
not likely to be affected by gastrointestinal digestion and can smoothly
reach the absorption site of the small intestine, the tolerance in the
stomach and intestines is high, and absorption of selenium by the human
body can be effectively enhanced. In addition, the active peptide for
enhancing selenium absorption in the present disclosure can be mutually
matched with other nutrients or food ingredients to prepare
selenium-enriched health-care foods, which have not only high selenium
absorption efficiency but also unique flavors and are easily accepted by
people.
Detailed Description
Specific embodiments of the present disclosure are further described
below. It should be noted that description of these embodiments is used to
help understand the present disclosure without limiting the present
disclosure. In addition, technical features involved in the embodiments of
the present disclosure described below can be combined with each other
as long as they do not conflict with each other.
Experimental methods in the following examples, unless otherwise
specified, are all conventional methods, and test materials used in the
D e s c r i p t i o n
following examples, unless otherwise specified, can be all purchased
through conventional commercial channels.
Example 1 Preparation method of an active peptide for enhancing
selenium absorption
(1) Fresh snakeheaded fish was used as a raw material and
slaughtered, and fish skin and fish skin mucus were collected separately;
(2) the collected fish skin was chopped and mashed, 4°C pure water
was added into the chopped fish skin at a material-liquid weight ratio of
1:3, the fish skin was prepared into fish paste by using the wet ultra-fine
pulverization technology, the pH of the fish paste was adjusted to 4.0,
then pepsin which was 30% of the weight of the fish paste was added,
mechanical stirring was performed at a rotation speed of 250 r/min for
enzymolysis for 2 hours, 5000 g of an obtained mixture was subjected to
centrifugal filtration, and the supernatant was kept and heated to 80°C
and maintained for 10 minutes to achieve the effects of sterilization and
enzyme inactivation.
(3) The supernatant was poured into a fermentation tank, based on
the mass of the fish paste (supernatant), 1.0% of whey protein powder,
2.65% of tapioca starch and 0.4% of carrot powder were added,
uniformly mixed and heated to 30°C, then 0.25% of selenium-enriched
yeast powder was added, uniformly mixed and continuously heated to
37 0 C, and anaerobic fermentation was performed in the sealed
D e s c r i p t io n
fermentation tank for 3.5 hours and terminated when the pH reached 4.8.
(4) According to the total mass of a fermentation solution, 0.002% of
selenoprotein was added into the fermentation solution, uniformly mixed
and subjected to ultrasonic treatment at the power of 350 W for 17.5
minutes, and the acidity (pH 4.9) and temperature (37.5°C) of the
fermentation solution were controlled to be unchanged in the ultrasonic
process.
(5) The fish skin mucus obtained by separation in step (1) was
uniformly mixed with mulberry leaf juice at a volume ratio of 1:1, an
obtained mixture was subjected to standing for 10 minutes, peanut oil
which was 13% of the total volume (volume percentage) and seaweed
polysaccharide which was 0.65 wt% of the total mass were added, and an
obtained mixture was subjected to homogeneous stirring at 44 0 C for 40
minutes for later use.
(6) A solution obtained in step (4) was slowly added into the
fermentation solution in step (3) at a volume ratio of 1:5, uniformly
stirred and packaged in a bag, the bag was vacuumized, sealed and
subjected to high static pressure treatment at 330 MPa for 10 minutes,
and then the pressure was reduced to 100 MPa and maintained for 10
minutes to obtain a selenium-rich active peptide solution for enhancing
selenium absorption.
According to a method in "GB/T 22492-2008 Soy Peptide Powder",
D e s c r i p t io n
it is measured that main protein components in the selenium-enriched
active peptide solution are 6-peptide and 8-peptide.
Example 2 Preparation method of an active peptide for enhancing
selenium absorption
(1) Fresh snakeheaded fish was used as a raw material and
slaughtered, and fish skin and fish skin mucus were collected separately;
(2) the collected fish skin was chopped and mashed, 4°C pure water
was added into the chopped fish skin at a material-liquid weight ratio of
1:3, the fish skin was prepared into fish paste by using the wet ultra-fine
pulverization technology, the pH of the fish paste was adjusted to 4.0,
then pepsin which was 20% of the weight of the fish paste was added,
mechanical stirring was performed at a rotation speed of 200 r/min for
enzymolysis for 2 hours, 5000 g of an obtained mixture was subjected to
centrifugal filtration, and the supernatant was kept and heated to 80°C
and maintained for 10 minutes to achieve the effects of sterilization and
enzyme inactivation.
(3) The supernatant was poured into a fermentation tank, based on
the mass of the fish paste (supernatant), 0.5% of whey protein powder,
2.5% of tapioca starch and 0.3% of carrot powder were added, uniformly
mixed and heated to 30°C, then 0.2% of selenium-enriched yeast powder
was added, uniformly mixed and continuously heated to 37°C, and
anaerobic fermentation was performed in the sealed fermentation tank for
D e s c r i p t io n
3.5 hours and terminated when the pH reached 4.8.
(4) According to the total mass of a fermentation solution, 0.001% of
selenoprotein was added into the fermentation solution, uniformly mixed
and subjected to ultrasonic treatment at the power of 300 W for 20
minutes, and the acidity (pH 4.8) and temperature (35°C) of the
fermentation solution were controlled to be unchanged in the ultrasonic
process.
(5) The fish skin mucus obtained by separation in step (1) was
uniformly mixed with mulberry leaf juice at a volume ratio of 1:1, an
obtained mixture was subjected to standing for 10 minutes, peanut oil
which was 10% of the total volume (volume percentage) and seaweed
polysaccharide which was 0.5 wt% of the total mass were added, and an
obtained mixture was subjected to homogeneous stirring at 42 0 C for 40
minutes for later use.
(6) A solution obtained in step (4) was slowly added into the
fermentation solution obtained in step (3) at a volume ratio of 1:4,
uniformly stirred and packaged in a bag, the bag was vacuumized, sealed
and subjected to high static pressure treatment at 300 MPa for 10 minutes,
and then the pressure was reduced to 80 MPa and maintained for 10
minutes to obtain a selenium-rich active peptide solution for enhancing
selenium absorption.
According to a method in "GB/T 22492-2008 Soy Peptide Powder",
D e s c r i p t io n
it is measured that main protein components in the selenium-enriched
active peptide solution are 6-peptide and 8-peptide.
Example 3 Preparation method of an active peptide for enhancing
selenium absorption
(1) Fresh snakeheaded fish was used as a raw material and
slaughtered, and fish skin and fish skin mucus were collected separately;
(2) the collected fish skin was chopped and mashed, 4°C pure water
was added into the chopped fish skin at a material-liquid weight ratio of
1:3, the fish skin was prepared into fish paste by using the wet ultra-fine
pulverization technology, the pH of the fish paste was adjusted to 4.0,
then pepsin which was 40% of the weight of the fish paste was added,
mechanical stirring was performed at a rotation speed of 300 r/min for
enzymolysis for 2 hours, 5000 g of an obtained mixture was subjected to
centrifugal filtration, and the supernatant was kept and heated to 80°C
and maintained for 10 minutes to achieve the effects of sterilization and
enzyme inactivation.
(3) The supernatant was poured into a fermentation tank, based on
the mass of the fish paste (supernatant), 1.5% of whey protein powder,
2.8% of tapioca starch and 0.5% of carrot powder were added, uniformly
mixed and heated to 30°C, then 0.3% of selenium-enriched yeast powder
was added, uniformly mixed and continuously heated to 37°C, and
anaerobic fermentation was performed in the sealed fermentation tank for
D e s c r i p t io n
3.5 hours and terminated when the pH reached 4.8.
(4) According to the total mass of a fermentation solution, 0.003% of
selenoprotein was added into the fermentation solution, uniformly mixed
and subjected to ultrasonic treatment at the power of 400 W for 15
minutes, and the acidity (pH 5.0) and temperature (40°C) of the
fermentation solution were controlled to be unchanged in the ultrasonic
process.
(5) The fish skin mucus obtained by separation in step (1) was
uniformly mixed with mulberry leaf juice at a volume ratio of 1:1, an
obtained mixture was subjected to standing for 10 minutes, peanut oil
which was 15% of the total volume (volume percentage) and seaweed
polysaccharide which was 0.8 wt% of the total mass were added, and an
obtained mixture was subjected to homogeneous stirring at 46 0 C for 30
minutes for later use.
(6) A solution obtained in step (4) was slowly added into the
fermentation solution obtained in step (3) at a volume ratio of 1:6,
uniformly stirred and packaged in a bag, the bag was vacuumized, sealed
and subjected to high static pressure treatment at 350 MPa for 10 minutes,
and then the pressure was reduced to 120 MPa and maintained for 10
minutes to obtain a selenium-rich active peptide solution for enhancing
selenium absorption.
According to a method in "GB/T 22492-2008 Soy Peptide Powder",
D e s c r i p t io n
it is measured that main protein components in the selenium-enriched
active peptide solution are 6-peptide and 8-peptide.
Example 4 Preparation method of a selenium-enriched emulsion beverage
for enhancing selenium absorption
1.9 wt% of whey protein, 0.0025 wt% of lactoferrin, 0.125 wt% of
edible fungus superfine powder, 1.6 wt% of maltodextrin, 1.6 wt% of a
perilla extract and 1.6 wt% of glucose were added into the
selenium-enriched active peptide solution prepared in Example 1,
uniformly stirred and mixed and subjected to high-temperature
sterilization to obtain the selenium-enriched emulsion beverage for
enhancing selenium absorption.
Example 5 Preparation method of a selenium-enriched emulsion beverage
for enhancing selenium absorption
1.8 wt% of whey protein, 0.002 wt% of lactoferrin, 0.1 wt% of edible
fungus superfine powder, 1.3 wt% of maltodextrin, 1.3 wt% of a perilla
extract and 1.3 wt% of glucose were added into the selenium-enriched
active peptide solution prepared in Example 1, uniformly stirred and
mixed and subjected to high-temperature sterilization to obtain the
selenium-enriched emulsion beverage for enhancing selenium absorption.
Example 6 Preparation method of a selenium-enriched emulsion beverage
for enhancing selenium absorption
2 wt% of whey protein, 0.003 wt% of lactoferrin, 0.15 wt% of edible
D e s c r i p t io n
fungus superfine powder, 1.3 wt% of maltodextrin, 1.3 wt% of a perilla
extract and 1.3 wt% of glucose were added into the selenium-enriched
active peptide solution prepared in Example 1, uniformly stirred and
mixed and subjected to high-temperature sterilization to obtain the
selenium-enriched emulsion beverage for enhancing selenium absorption.
Example 7 Preparation method of selenium-enriched health-care powder
for enhancing selenium absorption
The selenium-enriched active peptide solution prepared in Example 1
was spray-dried into light yellow selenium-enriched active peptide
powder, and then 5.5 wt% of whey protein powder, 0.9 wt% of walnut
powder, 0.0013 wt% of lactoferrin, 0.9 wt% of edible fungus superfine
powder, 9 wt% of maltodextrin and 0.008 wt% of solid DHA powder
were added into the selenium-enriched active peptide powder, uniformly
mixed and packaged to obtain the selenium-enriched health-care powder
for enhancing selenium absorption.
Example 8 Preparation method of selenium-enriched health-care powder
for enhancing selenium absorption
The selenium-enriched active peptide solution prepared in Example 1
was spray-dried into light yellow selenium-enriched active peptide
powder, and then 5 wt% of whey protein powder, 0.6 wt% of walnut
powder, 0.001 wt% of lactoferrin, 0.8 wt% of edible fungus superfine
powder, 8 wt% of maltodextrin and 0.005 wt% of solid DHA powder
D e s c r i p t io n
were added into the selenium-enriched active peptide powder, uniformly
mixed and packaged to obtain the selenium-enriched health-care powder
for enhancing selenium absorption.
Example 9 Preparation method of selenium-enriched health-care powder
for enhancing selenium absorption
The selenium-enriched active peptide solution prepared in Example 1
was spray-dried into light yellow selenium-enriched active peptide
powder, and then 6 wt% of whey protein powder, 1.2 wt% of walnut
powder, 0.0015 wt% of lactoferrin, 1.0 wt% of edible fungus superfine
powder, 10 wt% of maltodextrin and 0.01 wt% of solid DHA powder
were added into the selenium-enriched active peptide powder, uniformly
mixed and packaged to obtain the selenium-enriched health-care powder
for enhancing selenium absorption.
Experimental Example 1 In-vitro digestion and absorption experiment of
small intestinal mucosal cancer cells (Caco-2)
(1) Cytotoxicity test (survival rate):
Caco-2 cells were inoculated into a collagen-coated 96-well plate at a
density of 1x104 cells/well and incubated in a constant-temperatureCO 2
incubator at 37°C for 24 hours. After a culture medium was removed, 200
pL of samples of different concentrations were added into each well, and
8 to 10 parallel wells were prepared for each sample. After incubation in
D e s c r i p t io n
theCO 2 incubator at 37°C for 20 hours, 20 pL of MTT (detection reagent)
(5 mg/mL) was added into each well, and after constant-temperature
incubation for 4 hours, a precipitate was removed by centrifugation. Then,
150 pL of DMSO (dimethyl sulfoxide) was added into each well, and a
cell culture plate was shaken at a low speed for 10 minutes. The
absorbance was measured at 490 nm with a microplate reader, and finally
the cell survival rate (%) was calculated according to the following
formula:
Cell survival rate (%)=(B 1-Bo)*100/B 2-Bo.
In the formula: BO refers to the absorbance without cells; B1 refers to
the absorbance with addition of samples; B 2 refers to the absorbance
without addition of samples.
(2) Construction of an intestinal cell model in vitro
Caco-2 cells were inoculated into a 12-well plate at a density of
1x10' cells/well, a culture medium (Caco-2 cell culture medium with the
main component of DMEM and 20% FBS) was changed every other day
in the first week and changed every day in the second week, and after
culture for 21 days, an in-vitro intestinal cell model was obtained. The
Caco-2 cell culture medium was removed, the cells were washed twice
with a selenium-free buffer HBSS (cell culture solution) and preheated at
37°C for 10 minutes, the HBSS buffer was removed, different
concentrations (1 mg/mL, 5 mg/mL and 10 mg/mL) of samples (the
D e s c r i p t io n
selenium-enriched active peptide samples of Example 1, Example 4 and
Example 7) were added, the cells were cultured in an incubator for 2
hours, after reaction, the cells were washed twice with the HBSS buffer at
4°C to remove the residual extracting solution, 500 pL of 0.1% (v/v)
Triton X-100 cell lysate was added, repeat freezing and thawing were
carried out to lyse the cells, and then ultrasonic treatment was performed
for 10 minutes to obtain a cell suspension. The total protein mass
concentration (g/L) was measured with a BCA kit, another part was taken
from the cell suspension and centrifuged at a rotation speed of 15000
r/min for 10 minutes, the content of selenium ions in the solution was
determined by using an atomic absorption spectrophotometer, and the
AKP activity was determined by using an alkaline protease (AKP)
activity detection kit. During the experiment, a control group and a
sodium selenite group (commonly used selenium supplement products)
were set, wherein the control group included cells with addition of only
the culture medium, and the sodium selenite group included cells with
addition of a 0.02 mg/mL sodium selenite solution. At the same time, the
cell uptake rate was calculated according to the following formula:
Cell uptake rate (%)=C1/C2.
In the formula: C1 refers to the concentration of selenium in the cells;
C2 refers to the total protein concentration of the cells.
According to the survival rate of the small intestinal mucosal cancer
D e s c r i p t io n
cells (Caco-2) and the selenium uptake rate data in Table 1, it can be seen
that the survived rate of the Caco-2 cells treated with the samples of
Example 1, Example 4 and Example 7 is 94% or above and is slightly
lower than that of the control group (96.5%) and higher than that of the
sodium selenite group, which indicates that the samples of the present
disclosure are not toxic to Caco-2. At the same time, it can also be seen
that the selenium uptake rate of the Caco-2 cells in the samples of
Example 1, Example 4 and Example 7 is also significantly higher than
that of the sodium selenite group. Table 1 Survival rate and selenium uptake rate of small intestinal mucosal cancer cells (Caco-2)
Group Concentration of Cell survival Total retaining
samples rate amount of
(mg/mL) (%) selenium
(0%)
Control group 96.5±0.3
Sodium selenite 1 mg/mL 91.2±0.3 63.6±1.1
5 mg/mL 91.9+0.2 65.5+1.6
10 mg/nL 92.0+0.2 66.1+0.9
Example 1 mg/mL 94.5+0.5 76.1+0.6
5 mg/mL 94.7+0.4 77.8+1.0
10 mg/nL 95.0+0.3 77.4+0.8
D e s c r i p t io n
Example 4 1 mg/mL 94.1+0.3 75.9+0.7
5 mg/mL 94.5+0.3 76.0+1.3
10 mg/mL 94.6+0.2 77.8+1.2
Example 7 1 mg/mL 94.3+0.4 75.8+1.3
5 mg/mL 94.8+0.3 77.6+1.5
10 mg/mL 95.2+0.2 78.2+0.8
Experimental Example 2 Simulated gastrointestinal digestion test
(1) Simulated gastric digestion stage: the pH of simulated gastric
fluid (SGF) including 2 mg/mL of NaCl, 12 mmoL/L of HCl and 3.2
mg/mL of pepsin in deionized water was adjusted to 2.0. 5.0 mg/mL of
the samples (the selenium-enriched active peptide samples of Example 1,
Example 4 and Example 7) were mixed with SGF at a mass ratio of 1:1,
then the pH was adjusted to 2.0, an obtained mixture was continuously
stirred at a rotation speed of 100 r/min and at the constant temperature of
37°C for 2 hours to simulate gastric digestion, and a supernatant was
taken and measured with an atomic absorption spectrophotometer.
(2) Simulated small intestine digestion stage: simulated intestinal
fluid (SIF) containing a salt solution (100 mg of CaCl 2, 300 mg/mL of
NaCl, pH 7.0), a bile salt solution (375.0 mg of bile salt dissolved in 7.0
mL of deionized water, pH 7.0) and an enzyme solution (120.0 mg of
lipase dissolved in 5.0 mL of deionized water, pH 7.0) was prepared.
D e s c r i p t io n
After a gastric digestion stage was completed, the pH (60.0 mL) of a
previous solution (the solution of the simulated gastric digestion stage)
was raised to 7.0, and the prepared SIF was added into the previous
solution to make the final concentration of lipase and bile salt reach 1.6
mg/mL. The pH of an obtained mixture was adjusted to 7.0, then the
mixture was continuously subjected to shaking culture at a rotation speed
of 100 r/min at 37°C for 2 hours, collected, cooled in an ice-water bath
and then centrifuged at a rotation speed of 15000 r/min at 4°C for 30
minutes, and a supernatant was taken and measured with an atomic
absorption spectrophotometer.
During the experiment, a control group and a sodium selenite group
(commonly used selenium supplement products) were set, wherein the
control group included a mixture of the samples and deionized water, and
the sodium selenite group included a mixture of a 0.02 mg/mL sodium
selenite solution and the simulated gastric fluid.
Wherein, the retaining amount of selenium(%)= the content of
selenium with addition of digestive fluid/ the content of selenium without
addition of the digestive fluid*100%.
It can be seen from Table 2 that during the gastric digestion stage, the
content of selenium in the control group is not detected, and the retaining
amount of selenium in a sodium selenite sample is significantly lower
than that of the samples of Example 1, Example 4 and Example 7. After
D e s c r i p t i o n
gastric digestion, the previous gastric fluid is combined with the
simulated intestinal fluid for secondary digestion, the remaining amount
of selenium in the samples of Example 1, Example 4 and Example 7 in
the intestinal digestion stage is also higher than that of the sodium
selenite sample, but is further reduced, and the reason may be that the
ability of a compound to bind to selenium is reduced since the structure
of the compound is changed by trypsin. It is indicated that the structure of
the selenium-enriched active peptide sample of the present disclosure is
stable and is not likely to be affected by gastrointestinal digestion, the
selenium-enriched active peptide sample can smoothly reach the
absorption part of the small intestine, and the tolerance in the stomach
and intestines is high.
Table 2 Retaining amount of selenium in the gastric and intestinal stages
during in-vitro simulated digestion
Group Retaining amount of Retaining amount of
selenium in the selenium in the
simulated gastric simulated intestinal
digestion stage (%) digestion stage (%)
Control group
Sodium selenite 72.0+2.7 53.8+0.6
Example 1 81.3+4.1 71.0+0.5
Example 4 81.0+3.6 70.7+0.9
D e s c r i p t io n
Example 7 80.8+2.3 70.8±0.6
Experimental Example 3 Animal experiment of digestion and absorption
in mice
6-week-old clean mice were randomly divided into 3 groups with 12
mice in each group and fed with selenium-free feed to establish a
low-selenium model, the mice freely ate the feed and drank water, and the
room temperature was maintained to be (25+1)°C. The mice were fasted
6 hours before drug administration and freely drank water. The three
groups of mice were fed with the feed (the selenium-enriched active
peptide samples of Example 1, Example 4 and Example 7 and sodium
selenite) at the selenium content of 18 pg/kg • bw respectively by gavage,
600 pL of blood was collected from the tails before gavage and at 5, 10,
, 30, 40, 60, 80, 100 and 120 minutes after gavage separately, placed in
an EDTA anticoagulation tube and centrifuged at 3000 r/min for 10
minutes, and an upper layer of plasma was sucked into a centrifuge tube
and marked. The content of selenium in mouse plasma was detected by
using hydride generation-atomic fluorescence spectrometry (HG-AFS).
It can be seen from Table 3 that after gavage of the
selenium-enriched active peptide samples of Example 1, Example 4 and
Example 7 and the sodium selenite sample to the mice and after gavage
of the selenium-enriched active peptide samples of Example 1, Example
D e s c r i p t io n
4 and Example 7, the peak blood selenium value of the blood of the mice
is significantly higher than that of the sodium selenite sample, and the
peak appearance time of the peak blood selenium value is 10 minutes. It
is indicated that selenium in the selenium-enriched active peptide sample
of the present disclosure is more easily absorbed, the selenium
supplement effect is better than that of sodium selenite, and the reason
may be that the active peptide in the selenium-enriched active peptide
sample of the present disclosure mainly includes 6-peptide compounds
and 8-peptide compounds which are easily absorbed by the small
intestine and the duodenum.
Table 3 Digestion and absorption of selenium in mice after gavage
Group Total peak value of the Peak time of the blood
blood selenium value of the selenium value of the
blood of the mice (mg/L) blood of the mice (min)
Sodium 0.81 10
selenite
Example 1 1.23 10
Example 4 1.20 10
Example 7 1.99 10
The embodiments of the present disclosure are described in detail
above, but the present disclosure is not limited to the described
D e s c r i p t io n
embodiments. Various changes, modifications, substitutions and variants
can be made to these embodiments by those skilled in the art without
departing from the principle and spirit of the present disclosure, and the
changes, modifications, substitutions and variants are still within the
protection scope of the present disclosure.
Claims (5)
1. A preparation method of an active peptide for enhancing selenium
absorption, comprising the following steps:
S1. preparing fish skin into fish paste, adding pepsin for enzymolysis
treatment and collecting the supernatant;
S2. adding whey protein powder, tapioca starch, carrot powder and
selenium-enriched yeast powder into the supernatant obtained in step S1
and then performing anaerobic fermentation;
S3. adding selenoprotein into a fermentation solution obtained in
step S2 and then performing ultrasonic treatment;
S4. uniformly mixing fish skin mucus with mulberry leaf juice,
standing for a period of time, adding peanut oil and seaweed
polysaccharide and then performing homogeneous stirring;
S5. adding a solution obtained in step S4 into a fermentation solution
obtained in step S3, performing vacuumizing and high static pressure
treatment and finally performing depressurization to obtain the active
peptide for enhancing selenium absorption.
2. The preparation method of the active peptide for enhancing
selenium absorption according to claim 1, wherein in step S2, the whey
protein powder, the tapioca starch and the carrot powder are firstly added
into the supernatant and heated to 30°C, then the selenium-enriched yeast
powder is added, and finally the temperature is raised to 37°C for
anaerobic fermentation.
Cl a i m s
3. The preparation method of the active peptide for enhancing
selenium absorption according to claim 2, wherein in step S2, based on
the mass of the supernatant, the added amount of the whey protein
powder is 0.5-1.5%, the added amount of the tapioca starch is 2.5-2.8%,
the added amount of the carrot powder is 0.3-0.5%, and the added amount
of the selenium-enriched yeast powder is 0.2-0.3%.
4. The preparation method of the active peptide for enhancing
selenium absorption according to claim 1, wherein in step S4, the volume
ratio of the fish skin mucus to the mulberry leaf juice is 1:1.
5. The preparation method of the active peptide for enhancing
selenium absorption according to claim 1, wherein in step S5, the high
static pressure treatment is performed at 300-350 MPa for 10 minutes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011414163.6A CN112481341B (en) | 2020-12-07 | 2020-12-07 | Preparation method and application of selenium absorption enhancing active peptide |
CN202011414163.6 | 2020-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2020104369A4 true AU2020104369A4 (en) | 2021-03-18 |
Family
ID=74940272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2020104369A Ceased AU2020104369A4 (en) | 2020-12-07 | 2020-12-29 | Preparation Method of Active Peptide for Enhancing Selenium Absorption and Application Thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112481341B (en) |
AU (1) | AU2020104369A4 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112970997A (en) * | 2021-04-02 | 2021-06-18 | 汕尾市五丰海洋生物科技有限公司 | Preparation method of selenoprotein powder and selenoprotein tablet |
CN114752642B (en) * | 2022-03-24 | 2024-07-12 | 华南农业大学 | Selenium-enriched walnut antihypertensive peptide and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200077682A1 (en) * | 2015-01-16 | 2020-03-12 | Welldrinks Ltd | Beverage with collagen and additional additives |
CN108138206B (en) * | 2015-08-07 | 2022-03-29 | 龟甲万株式会社 | Method for preparing ergodiselenine |
CN108893514B (en) * | 2018-07-20 | 2022-05-17 | 广州医科大学 | Whey protein peptide-selenium chelate with antioxidant activity and preparation method and application thereof |
CN109430526A (en) * | 2018-12-27 | 2019-03-08 | 广西壮佳霖农业投资有限公司 | A kind of lactalbumin Se-enriched bio feed and its application |
-
2020
- 2020-12-07 CN CN202011414163.6A patent/CN112481341B/en active Active
- 2020-12-29 AU AU2020104369A patent/AU2020104369A4/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CN112481341B (en) | 2022-09-23 |
CN112481341A (en) | 2021-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101228951B (en) | Preparing method of biologic compound amylose nutrient fluid | |
AU2020104369A4 (en) | Preparation Method of Active Peptide for Enhancing Selenium Absorption and Application Thereof | |
CN104663246B (en) | The production method of selenium-enriched high-calcium edible fungus cluster | |
CN105641000A (en) | Antitumor composition containing grifola frondosus extract and preparation method thereof | |
CN106561264A (en) | High-selenium high-cordycepin-content cordyceps militaris culturing method and culture medium thereof | |
CN107223986A (en) | A kind of selenium-rich health-care polypeptide product and preparation method thereof | |
CN106174475B (en) | A kind of selenoprotein holoside nutrient composite powder and preparation method thereof | |
CN108208313A (en) | A kind of poultry feed that natural astaxanthin, selenium and low cholesterol fowl health-care eggs are rich in for production and preparation method thereof | |
CN105878397A (en) | Composition capable of regulating transportation stress of cattle and sheep | |
CN104711203A (en) | Selenium-rich germanium yeast powder | |
CN103262980A (en) | Selenium germanium chromium elements-enriched vitamin spirulina health-care rice flour | |
CN104621429B (en) | A kind of selenium-rich organic appetite-stimulating indigestion-relieving jam | |
CN106923342A (en) | A kind of selenium-rich passion fruit amino acid lozenge and preparation method thereof | |
CN107896921B (en) | Tremella biotransformation composition of maca and dioscorea opposita and preparation method thereof | |
KR101317935B1 (en) | A culture medium for making the complex vegitables watery kimchi and method for producing thereof using the same | |
RU2473679C2 (en) | METHOD OF PRODUCING SELENIUM-CONTAINING BIOMASS PREPARATION OF Laetiporus sulphureus MZ-22 | |
CN103385465A (en) | Natural green element convenient rice | |
KR20120137665A (en) | Fermented natural vitamin using effective micro-organisms and manufacturing method thereof | |
CN1252835A (en) | Dietary supplementation with, and method for preparation of yeast-derived selenium salt | |
CN106072088A (en) | Thallus Laminariae (Thallus Eckloniae) Ganoderma mycelium is prepared for culture medium with Thallus Laminariae (Thallus Eckloniae) | |
KR101856693B1 (en) | Method for preparing fermented mixture comprising Laminaria japonica, Undaria pinnatifida Suringer and hizikia fusiforme and composition for enhancing antioxidant activity and immune activity comprising fermented mixture prepared thereby | |
KR101043807B1 (en) | A functional salt and a method of preparing the same | |
CN106668841A (en) | Anti-tumor yak ossein protein peptide composition and preparation method thereof | |
KR101152910B1 (en) | Processfood of a cherry tomato for improving a prostate function and the manufacturing method | |
CN115806920B (en) | Zinc-rich lactobacillus paracasei and method for producing organic zinc |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) | ||
MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |